Vivid Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Sell
683
-6,304
-90% -$2.16M 0.09% 68
2026
Q1
$2.46M Buy
+6,987
New +$2.49M 0.99% 40
2024
Q4
Sell
-6,711
Closed -$2.16M 61
2024
Q3
$2.16M Buy
6,711
+5,971
+807% +$1.95M 1.13% 41
2024
Q2
$231K Sell
740
-1,831
-71% -$538K 0.13% 67
2024
Q1
$731K Sell
2,571
-106
-4% -$31K 0.46% 39
2023
Q4
$771K Buy
+2,677
New +$729K 0.52% 36

Other funds holding AMGN

Vivid Wealth Management's AMGN Position: Q2 2026 in Review

Vivid Wealth Management reduced its Amgen (AMGN) stake by 90% in Q2 2026, selling an estimated $2.16M and leaving 683 shares worth $247K. The position accounts for 0.09% of the portfolio, ranked #68.

Vivid Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 6 quarters since. The position peaked at $2.46M in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Vivid Wealth Management held 683 shares of Amgen worth $247K as of Q2 2026.
  • Vivid Wealth Management sold 6,304 Amgen shares in Q2 2026, an estimated $2.16M.
  • Amgen made up 0.09% of Vivid Wealth Management's portfolio in Q2 2026, its #68 holding.
  • Vivid Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 6 quarters since.
  • Vivid Wealth Management's Amgen position peaked at $2.46M in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Vivid Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.